Hindorf / Parrish / Wayne / L. A. / St. Louis / Orlando / Harris / Bedford / Madison / Fayette / London / /
Company
Millipore Corp. / Wisconsin State Laboratory / Wisconsin State Hygiene Laboratory / Naser S. A. / M. Regueiro L. P. / Sigma-Aldrich Co. / M. Strother S. A. / Travis S. P. / Becton Dickinson / E. O. Kistner L. P. / /
Country
Japan / United Kingdom / Israel / Northern Ireland / South Korea / Czech Republic / /
Currency
USD / TTD / / /
Event
FDA Phase / /
Facility
Chungnam National University / Johne’s Testing Center / University of Central Florida / Wisconsin State Laboratory of Hygiene / University of Nebraska / College of Medicine / University of Wisconsin-Madison / / /
IndustryTerm
food / treatment of inflammatory bowel disease / drug-free media / stock drug solutions / gastrointestinal antigen processing / 12B media / paratuberculosis culture media / Crohn’s disease therapy / /
MedicalCondition
humanorigin M. paratuberculosis / abdominal tuberculosis / anti-M. paratuberculosis / paratuberculosis infection / complete M. paratuberculosis / chronic inflammatory bowel disease / infectious agent / multidrug-resistant tuberculosis / Mycobacterium paratuberculosis / avium subspecies paratuberculosis / AIDS / infection / M. paratuberculosis / Human and animal M. paratuberculosis / Mycobacterium avium subspecies paratuberculosis cause Crohn’s disease / inflammatory bowel disease / bovine-origin Mycobacterium paratuberculosis / strain / Crohn disease / lower M. paratuberculosis CFU / Bovine- and human-origin M. paratuberculosis / disease / Mycobacterium tuberculosis / Crohn’s disease / Mycobacterium avium subspecies paratuberculosis / significant anti-M. paratuberculosis / viable M. paratuberculosis / Crohn’s disease patient M. paratuberculosis / paratuberculosis / human-origin M. paratuberculosis / primary M. paratuberculosis / inflammation / CFU M. paratuberculosis / tuberculosis / /
MedicalTreatment
antibiotics / immunosuppressive therapy / /
MusicGroup
Phase III / Phase IV / /
NaturalFeature
Hermon / /
Organization
SP SS / Michael T. Collins* Department of Pathobiological Sciences / American Society for Microbiology / Association of NOD2 / Department of Microbiology / FDA / Chungnam National University / National Committee for Clinical Laboratory Standards / Laboratory Standards Institute / Johne’s Testing Center / School of Veterinary Medicine / the University of Nebraska / University of Central Florida / College of Medicine / University of Wisconsin / /
Person
P. R. Thomas / Sung Jae Shin / L. Su / V / Nat / Saleh Naser / Raul Barletta / S. Sreevatsan / AZA AZM CIP / M. Gassull / V / Seth Kramer / Michael T. Collins / P. W. San / Jr. / C. G. Ko / E. J. Manning / A. Hasselmeyer / Drug family / Again / Robert Greenstein / H. Frenzel / L. De / V / Gui / / /
Position
Fireman / G. P. / Corresponding author / General / MP / King / Fisher / /
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Feb. 2008, p. 418–/$08.00⫹0 doi:AACCopyright © 2008, American Society for Microbiology. All Rights Reserved. Vol. 52, No. 2